WHO ICTRP trial
The effect of intravenous trehalose on Fatigue in MS
IRCT20181022041407N14 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20181022041407N14 |
|---|---|
| Public title | The effect of intravenous trehalose on Fatigue in MS |
| Scientific title | Investigating the effect of intravenous Trehalose on the fatigue and performance of a patient with Multiple Sclerosis |
| Primary sponsor | Mashhad University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Multiple Sclerosis. G35;Multiple S |
| Interventions | Intervention group: IV Trehalose (15 g per week) for 12 weeks by Dr.Rajabi Pharmaceutical Co.. |
| Registration date | Jun 19, 2025 |
| Target size | 1 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: